chr10-113567325-A-G

Position:

• chr10-113567325-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_004132.5(HABP2):​c.70-164A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0651 in 152,184 control chromosomes in the GnomAD database, including 382 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency: Genomes: 𝑓 0.065 (382 hom., cov: 32)
• Consequence: HABP2 NM_004132.5 intron
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: 0.0580

Genes affected

HABP2 (HGNC:4798): (hyaluronan binding protein 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by hepatocytes and proteolytically processed to generate heavy and light chains that form the mature heterodimer. Further autoproteolysis leads to smaller, inactive peptides. This extracellular protease binds hyaluronic acid and may play a role in the coagulation and fibrinolysis systems. Mutations in this gene are associated with nonmedullary thyroid cancer and susceptibility to venous thromboembolism. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.85).
• BP6: Variant 10-113567325-A-G is Benign according to our data. Variant chr10-113567325-A-G is described in ClinVar as [Benign]. Clinvar id is 1280179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
HABP2	NM_004132.5	c.70-164A>G		intron_variant		ENST00000351270.4
HABP2	NM_001177660.3	c.-9-164A>G		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
HABP2	ENST00000351270.4	c.70-164A>G		intron_variant		1	NM_004132.5	P1
HABP2	ENST00000542051.5	c.-9-164A>G		intron_variant		2

Frequencies

GnomAD3 genomes AF: 0.0651 AC: 9903 AN: 152066 Hom.: 380 Cov.: 32

Gnomad AFR AF: 0.0372

Gnomad AMI AF: 0.0901

Gnomad AMR AF: 0.0563

Gnomad ASJ AF: 0.0672

Gnomad EAS AF: 0.0428

Gnomad SAS AF: 0.109

Gnomad FIN AF: 0.0300

Gnomad MID AF: 0.123

Gnomad NFE AF: 0.0870

Gnomad OTH AF: 0.0798

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.0651 AC: 9910 AN: 152184 Hom.: 382 Cov.: 32 AF XY: 0.0636 AC XY: 4734 AN XY: 74406

Gnomad4 AFR AF: 0.0373

Gnomad4 AMR AF: 0.0563

Gnomad4 ASJ AF: 0.0672

Gnomad4 EAS AF: 0.0427

Gnomad4 SAS AF: 0.110

Gnomad4 FIN AF: 0.0300

Gnomad4 NFE AF: 0.0870

Gnomad4 OTH AF: 0.0804

Alfa AF: 0.0818 Hom.: 753

Bravo AF: 0.0671

Asia WGS AF: 0.0680 AC: 236 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:2

Benign, criteria provided, single submitter	not provided	Breakthrough Genomics, Breakthrough Genomics	-	- -
Benign, criteria provided, single submitter	clinical testing	GeneDx	Jan 10, 2019	- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.85
CADD	Benign	1.1
DANN	Benign	0.36

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs11575668; hg19: chr10-115327084;